29 February 2024 false No description of principal activity Taxfiler 2024.6 14658166 business:PrivateLimitedCompanyLtd 2024-02-29 2025-02-28 14658166 2024-02-28 14658166 2024-02-29 2025-02-28 14658166 business:AuditExemptWithAccountantsReport 2024-02-29 2025-02-28 14658166 business:AbridgedAccounts 2024-02-29 2025-02-28 14658166 2025-02-28 14658166 business:Director1 2024-02-29 2025-02-28 14658166 business:RegisteredOffice 2024-02-29 2025-02-28 14658166 2024-02-28 14658166 core:WithinOneYear 2025-02-28 14658166 core:WithinOneYear 2024-02-28 14658166 core:ShareCapital core:PreviouslyStatedAmount 2025-02-28 14658166 core:ShareCapital core:PreviouslyStatedAmount 2024-02-28 14658166 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-02-28 14658166 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-02-28 14658166 core:PreviouslyStatedAmount 2025-02-28 14658166 core:PreviouslyStatedAmount 2024-02-28 14658166 business:SmallEntities 2024-02-29 2025-02-28 14658166 countries:EnglandWales 2024-02-29 2025-02-28 14658166 core:FurnitureFittings 2024-02-29 2025-02-28 14658166 2023-03-01 2024-02-28 iso4217:GBP xbrli:pure
Company Registration No. 14658166 (England and Wales)
NK PHARM LIMITED Unaudited accounts for the period from 29 February 2024 to 28 February 2025
NK PHARM LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
NK PHARM LIMITED Company Information for the period from 29 February 2024 to 28 February 2025
Director
Nabeel Adam Khan
Company Number
14658166 (England and Wales)
Registered Office
33 LOWFIELD ROAD STOCKPORT SK2 6RN UNITED KINGDOM
- 3 -
NK PHARM LIMITED Statement of financial position as at 28 February 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
600
900
Current assets
Cash at bank and in hand
28,303
26,162
Creditors: amounts falling due within one year
(30,617)
(20,090)
Net current (liabilities)/assets
(2,314)
6,072
Net (liabilities)/assets
(1,714)
6,972
Capital and reserves
Called up share capital
100
100
Profit and loss account
(1,814)
6,872
Shareholders' funds
(1,714)
6,972
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the period in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 November 2025 and were signed on its behalf by
Nabeel Adam Khan Director Company Registration No. 14658166
- 4 -
NK PHARM LIMITED Notes to the Accounts for the period from 29 February 2024 to 28 February 2025
1
Statutory information
NK PHARM LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14658166. The registered office is 33 LOWFIELD ROAD, STOCKPORT, SK2 6RN, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
£1200
4
Tangible fixed assets
Total
£
Cost or valuation
At 29 February 2024
1,200
At 28 February 2025
1,200
Depreciation
At 29 February 2024
300
Charge for the period
300
At 28 February 2025
600
Net book value
At 28 February 2025
600
At 28 February 2024
900
5
Average number of employees
During the period the average number of employees was 1 (2024: 1).
- 5 -